Cidara Therapeutics (CDTX) PT Raised to $173 at Citizens
Tweet Send to a Friend
Citizens analyst Roy Buchanan raised the price target on Cidara Therapeutics (NASDAQ: CDTX) to $173.00 (from $153.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
